Cargando…

Population pharmacokinetics of artesunate and amodiaquine in African children

BACKGROUND: Pharmacokinetic (PK) data on amodiaquine (AQ) and artesunate (AS) are limited in children, an important risk group for malaria. The aim of this study was to evaluate the PK properties of a newly developed and registered fixed dose combination (FDC) of artesunate and amodiaquine. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stepniewska, Kasia, Taylor, Walter, Sirima, Sodiomon B, Ouedraogo, Esperance B, Ouedraogo, Alphonse, Gansané, Adama, Simpson, Julie A, Morgan, Caroline C, White, Nicholas J, Kiechel, Jean-René
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224946/ https://www.ncbi.nlm.nih.gov/pubmed/19691851 http://dx.doi.org/10.1186/1475-2875-8-200

Ejemplares similares

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum
por: Sirima, Sodiomon B, et al.
Publicado: (2009)

Fixed dose artesunate amodiaquine – a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine
por: Ogutu, Bernhards, et al.
Publicado: (2014)

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Tolerability and pharmacokinetics of non-fixed and fixed combinations of artesunate and amodiaquine in Malaysian healthy normal volunteers
por: Navaratnam, Visweswaran, et al.
Publicado: (2009)

Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
por: Orrell, Catherine, et al.
Publicado: (2008)

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2013)

Plasmodium falciparum genotypes diversity in symptomatic malaria of children living in an urban and a rural setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2009)

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial
por: Konaté, Amadou T., et al.
Publicado: (2011)

Variation in haematological parameters in children less than five years of age with asymptomatic Plasmodium infection: implication for malaria field studies
por: Gansane, Adama, et al.
Publicado: (2013)

Access to artesunate-amodiaquine, quinine and other anti-malarials: policy and markets in Burundi
por: Amuasi, John H, et al.
Publicado: (2011)

Population Pharmacokinetics of the Antimalarial Amodiaquine: a Pooled Analysis To Optimize Dosing
por: Ali, Ali Mohamed, et al.
Publicado: (2018)

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2009)

A controlled, parallel, cluster-randomized trial of community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2013)

Household costs and time to treatment for children with severe febrile illness in rural Burkina Faso: the role of rectal artesunate
por: Castellani, Joëlle, et al.
Publicado: (2018)

Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009
por: Zwang, Julien, et al.
Publicado: (2014)

Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial
por: Konaté, Amadou T., et al.
Publicado: (2011)

Correction: Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children
por: Sirima, Sodiomon B., et al.
Publicado: (2010)

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership
por: Lacaze, Catherine, et al.
Publicado: (2011)

Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India
por: Anvikar, Anupkumar R, et al.
Publicado: (2012)

Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa
por: Zwang, Julien, et al.
Publicado: (2012)

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis
por: Zwang, Julien, et al.
Publicado: (2009)

In vitro antiplasmodial and cytotoxic properties of some medicinal plants from western Burkina Faso
por: Sanon, Souleymane, et al.
Publicado: (2013)

Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali
por: Tekete, Mamadou M, et al.
Publicado: (2011)

Efficacy and safety of artemether + lumefantrine, artesunate + sulphamethoxypyrazine-pyrimethamine and artesunate + amodiaquine and sulphadoxine-pyrimethamine + amodiaquine in the treatment of uncomplicated falciparum malaria in Bangui, Central African Republic: a randomized trial
por: Djallé, Djibrine, et al.
Publicado: (2014)

Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children
por: Guidi, Monia, et al.
Publicado: (2019)

Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods
por: Tiono, Alfred B., et al.
Publicado: (2014)

Evaluation of the Comparative Efficacy and Safety of Artemether-Lumefantrine, Artesunate-Amodiaquine and Artesunate-Amodiaquine-Chlorpheniramine (Artemoclo™) for the Treatment of Acute Uncomplicated Malaria in Nigerian Children
por: Falade, C.O., et al.
Publicado: (2014)

Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
por: Zongo, Issaka, et al.
Publicado: (2020)

Different approaches for delivery of Intermittent Preventive Treatment (IPT) to pregnant women in Burkina Faso
por: Ouédraogo, Alphonse, et al.
Publicado: (2010)

Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania
por: Mutabingwa, Theonest K., et al.
Publicado: (2009)

Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate–amodiaquine fixed dose combination or artemether–lumefantrine in Liberia
por: Otienoburu, Sabina Dahlström, et al.
Publicado: (2016)

Effect of Mass Artesunate-Amodiaquine Distribution on Mortality of Patients With Ebola Virus Disease During West African Outbreak
por: Garbern, Stephanie C, et al.
Publicado: (2019)

Artesunate/Amodiaquine Malaria Treatment for Equatorial Guinea (Central Africa)
por: Charle, Pilar, et al.
Publicado: (2013)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
por: Raobela, Oméga, et al.
Publicado: (2018)

Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine
por: Walimbwa, Stephen I., et al.
Publicado: (2019)

Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate-Amodiaquine in Cambodia
por: Mairet-Khedim, Melissa, et al.
Publicado: (2020)

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age
por: Ouédraogo, Alphonse, et al.
Publicado: (2013)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Pharmacokinetics and Safety Profile of Artesunate-Amodiaquine Coadministered with Antiretroviral Therapy in Malaria-Uninfected HIV-Positive Malawian Adults
por: Banda, Clifford G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_abl6lj7n4je44kl24cibtk4a71